{"target":{"股票代码":"300760.SZ","股票名称":"迈瑞医疗","当前价格":199.99,"总市值":242476154386.06,"流通市值":242468999743.81,"总股本":1212441394.0,"流通股本":1212405619.0,"分析时间":"2025-12-26 00:00:00","PE统计":{"扣非PE(TTM)":28.635,"扣非PE(TTM)备注":"","动态PE":24.023,"动态PE备注":"","当前PEG":null,"PEG备注":"比较 2024-09-30 vs 2025-09-30；利润表字段 DEDUCT_PARENT_NETPROFIT_YOY；PEG因PE或增速为非正值而置为None","净利润增长率":-0.285},"PB统计":{"当前PB":5.48},"PS统计":{"当前PS":7.331},"历史PE数据":[{"报告期":"2023-12-31","TTM净利润(亿元)":114.337,"TTM每股收益(元)":9.43,"股价(元)":276.81,"PE":29.353,"PB":10.144},{"报告期":"2024-03-31","TTM净利润(亿元)":119.416,"TTM每股收益(元)":9.849,"股价(元)":268.1,"PE":27.22,"PB":8.986},{"报告期":"2024-06-30","TTM净利润(亿元)":124.73,"TTM每股收益(元)":10.287,"股价(元)":278.49,"PE":27.071,"PB":8.692},{"报告期":"2024-09-30","TTM净利润(亿元)":121.847,"TTM每股收益(元)":10.05,"股价(元)":285.27,"PE":28.386,"PB":9.324},{"报告期":"2024-12-31","TTM净利润(亿元)":114.42,"TTM每股收益(元)":9.437,"股价(元)":249.78,"PE":26.468,"PB":8.446},{"报告期":"2025-03-31","TTM净利润(亿元)":109.356,"TTM每股收益(元)":9.019,"股价(元)":229.21,"PE":25.413,"PB":7.201},{"报告期":"2025-06-30","TTM净利润(亿元)":90.114,"TTM每股收益(元)":7.432,"股价(元)":222.04,"PE":29.874,"PB":6.896},{"报告期":"2025-09-30","TTM净利润(亿元)":84.678,"TTM每股收益(元)":6.984,"股价(元)":244.1,"PE":34.951,"PB":7.531}],"历史PEG数据":[{"报告期":"2023-12-31","PE":29.353,"净利润同比增长率(%)":20.038,"PEG":1.465},{"报告期":"2024-03-31","PE":27.22,"净利润同比增长率(%)":20.081,"PEG":1.356},{"报告期":"2024-06-30","PE":27.071,"净利润同比增长率(%)":16.39,"PEG":1.652},{"报告期":"2024-09-30","PE":28.386,"净利润同比增长率(%)":7.754,"PEG":3.661},{"报告期":"2024-12-31","PE":26.468,"净利润同比增长率(%)":0.073,"PEG":364.558},{"报告期":"2025-03-31","PE":25.413,"净利润同比增长率(%)":-16.675,"PEG":null},{"报告期":"2025-06-30","PE":29.874,"净利润同比增长率(%)":-32.935,"PEG":null},{"报告期":"2025-09-30","PE":34.951,"净利润同比增长率(%)":-28.497,"PEG":null}],"价格极值回顾":[{"类别":"三年最高价","价格日期":"2023-01-16","价格(元)":316.23,"参考财报日期":"2022-12-31","TTM净利润(亿元)":95.251,"扣非PE":40.253,"扣非净利润同比增长率(%)":21.333,"PEG":1.887},{"类别":"一年最高价","价格日期":"2025-02-14","价格(元)":256.44,"参考财报日期":"2024-12-31","TTM净利润(亿元)":114.42,"扣非PE":27.173,"扣非净利润同比增长率(%)":0.073,"PEG":374.278},{"类别":"三个月最高价","价格日期":"2025-10-09","价格(元)":246.63,"参考财报日期":"2025-09-30","TTM净利润(亿元)":84.678,"扣非PE":35.313,"扣非净利润同比增长率(%)":-28.497,"PEG":null},{"类别":"三年最低价","价格日期":"2025-11-24","价格(元)":193.0,"参考财报日期":"2025-09-30","TTM净利润(亿元)":84.678,"扣非PE":27.634,"扣非净利润同比增长率(%)":-28.497,"PEG":null}]},"similar":[{"股票代码":"688271.SH","股票名称":"联影医疗","当前价格":130.32,"总市值":107404268996.16,"流通市值":107404268996.16,"总股本":824157988.0,"流通股本":824157988.0,"分析时间":"2025-12-26 00:00:00","PE统计":{"扣非PE(TTM)":67.151,"扣非PE(TTM)备注":"","动态PE":71.907,"动态PE备注":"","当前PEG":0.529,"PEG备注":"比较 2024-09-30 vs 2025-09-30；利润表字段 DEDUCT_PARENT_NETPROFIT_YOY；使用扣非PE(TTM)","净利润增长率":1.269},"PB统计":{"当前PB":5.162},"PS统计":{"当前PS":8.8},"历史PE数据":[{"报告期":"2023-12-31","TTM净利润(亿元)":16.649,"TTM每股收益(元)":2.02,"股价(元)":136.36,"PE":67.502,"PB":5.957},{"报告期":"2024-03-31","TTM净利润(亿元)":16.884,"TTM每股收益(元)":2.049,"股价(元)":129.19,"PE":63.06,"PB":5.538},{"报告期":"2024-06-30","TTM净利润(亿元)":16.758,"TTM每股收益(元)":2.033,"股价(元)":109.18,"PE":53.694,"PB":4.594},{"报告期":"2024-09-30","TTM净利润(亿元)":13.002,"TTM每股收益(元)":1.578,"股价(元)":127.69,"PE":80.937,"PB":5.474},{"报告期":"2024-12-31","TTM净利润(亿元)":10.103,"TTM每股收益(元)":1.226,"股价(元)":126.22,"PE":102.962,"PB":5.227},{"报告期":"2025-03-31","TTM净利润(亿元)":10.886,"TTM每股收益(元)":1.321,"股价(元)":121.81,"PE":92.217,"PB":4.949},{"报告期":"2025-06-30","TTM净利润(亿元)":11.78,"TTM每股收益(元)":1.429,"股价(元)":127.55,"PE":89.237,"PB":5.055},{"报告期":"2025-09-30","TTM净利润(亿元)":15.995,"TTM每股收益(元)":1.941,"股价(元)":151.57,"PE":78.1,"PB":6.003}],"历史PEG数据":[{"报告期":"2023-12-31","PE":67.502,"净利润同比增长率(%)":25.382,"PEG":2.659},{"报告期":"2024-03-31","PE":63.06,"净利润同比增长率(%)":8.522,"PEG":7.4},{"报告期":"2024-06-30","PE":53.694,"净利润同比增长率(%)":1.392,"PEG":38.578},{"报告期":"2024-09-30","PE":80.937,"净利润同比增长率(%)":-44.0,"PEG":null},{"报告期":"2024-12-31","PE":102.962,"净利润同比增长率(%)":-39.315,"PEG":null},{"报告期":"2025-03-31","PE":92.217,"净利润同比增长率(%)":26.086,"PEG":3.535},{"报告期":"2025-06-30","PE":89.237,"净利润同比增长率(%)":21.014,"PEG":4.247},{"报告期":"2025-09-30","PE":78.1,"净利润同比增长率(%)":126.941,"PEG":0.615}],"价格极值回顾":[{"类别":"三年最高价","价格日期":"2023-02-06","价格(元)":189.03,"参考财报日期":"2022-12-31","TTM净利润(亿元)":13.278,"扣非PE":117.326,"扣非净利润同比增长率(%)":13.91,"PEG":8.435},{"类别":"一年最高价","价格日期":"2025-09-08","价格(元)":158.16,"参考财报日期":"2025-06-30","TTM净利润(亿元)":11.78,"扣非PE":110.653,"扣非净利润同比增长率(%)":21.014,"PEG":5.266},{"类别":"三个月最高价","价格日期":"2025-10-09","价格(元)":157.41,"参考财报日期":"2025-09-30","TTM净利润(亿元)":15.995,"扣非PE":81.109,"扣非净利润同比增长率(%)":126.941,"PEG":0.639},{"类别":"三年最低价","价格日期":"2024-09-23","价格(元)":92.59,"参考财报日期":"2024-06-30","TTM净利润(亿元)":16.758,"扣非PE":45.535,"扣非净利润同比增长率(%)":1.392,"PEG":32.716}]},{"股票代码":"300003.SZ","股票名称":"乐普医疗","当前价格":16.24,"总市值":29936757000.08,"流通市值":25641071369.2,"总股本":1843396367.0,"流通股本":1578883705.0,"分析时间":"2025-12-26 00:00:00","PE统计":{"扣非PE(TTM)":69.903,"扣非PE(TTM)备注":"","动态PE":22.863,"动态PE备注":"","当前PEG":2.481,"PEG备注":"比较 2024-09-30 vs 2025-09-30；利润表字段 DEDUCT_PARENT_NETPROFIT_YOY；使用扣非PE(TTM)","净利润增长率":0.282},"PB统计":{"当前PB":1.687},"PS统计":{"当前PS":4.785},"历史PE数据":[{"报告期":"2023-12-31","TTM净利润(亿元)":11.231,"TTM每股收益(元)":0.609,"股价(元)":15.29,"PE":25.096,"PB":1.764},{"报告期":"2024-03-31","TTM净利润(亿元)":10.171,"TTM每股收益(元)":0.552,"股价(元)":13.03,"PE":23.615,"PB":1.467},{"报告期":"2024-06-30","TTM净利润(亿元)":8.654,"TTM每股收益(元)":0.469,"股价(元)":14.34,"PE":30.546,"PB":1.663},{"报告期":"2024-09-30","TTM净利润(亿元)":5.713,"TTM每股收益(元)":0.31,"股价(元)":12.92,"PE":41.691,"PB":1.508},{"报告期":"2024-12-31","TTM净利润(亿元)":2.214,"TTM每股收益(元)":0.12,"股价(元)":11.12,"PE":92.573,"PB":1.348},{"报告期":"2025-03-31","TTM净利润(亿元)":1.024,"TTM每股收益(元)":0.056,"股价(元)":11.2,"PE":201.655,"PB":1.322},{"报告期":"2025-06-30","TTM净利润(亿元)":2.365,"TTM每股收益(元)":0.128,"股价(元)":13.66,"PE":106.482,"PB":1.594},{"报告期":"2025-09-30","TTM净利润(亿元)":4.283,"TTM每股收益(元)":0.232,"股价(元)":17.52,"PE":75.412,"PB":2.014}],"历史PEG数据":[{"报告期":"2023-12-31","PE":25.096,"净利润同比增长率(%)":-47.603,"PEG":null},{"报告期":"2024-03-31","PE":23.615,"净利润同比增长率(%)":-18.846,"PEG":null},{"报告期":"2024-06-30","PE":30.546,"净利润同比增长率(%)":-28.482,"PEG":null},{"报告期":"2024-09-30","PE":41.691,"净利润同比增长率(%)":-42.915,"PEG":null},{"报告期":"2024-12-31","PE":92.573,"净利润同比增长率(%)":-80.284,"PEG":null},{"报告期":"2025-03-31","PE":201.655,"净利润同比增长率(%)":-26.082,"PEG":null},{"报告期":"2025-06-30","PE":106.482,"净利润同比增长率(%)":2.325,"PEG":45.792},{"报告期":"2025-09-30","PE":75.412,"净利润同比增长率(%)":28.176,"PEG":2.676}],"价格极值回顾":[{"类别":"三年最高价","价格日期":"2023-05-29","价格(元)":23.23,"参考财报日期":"2023-03-31","TTM净利润(亿元)":21.587,"扣非PE":19.837,"扣非净利润同比增长率(%)":2.782,"PEG":7.131},{"类别":"一年最高价","价格日期":"2025-08-25","价格(元)":20.44,"参考财报日期":"2025-06-30","TTM净利润(亿元)":2.365,"扣非PE":159.334,"扣非净利润同比增长率(%)":2.325,"PEG":68.52},{"类别":"三个月最高价","价格日期":"2025-11-03","价格(元)":18.2,"参考财报日期":"2025-09-30","TTM净利润(亿元)":4.283,"扣非PE":78.339,"扣非净利润同比增长率(%)":28.176,"PEG":2.78},{"类别":"三年最低价","价格日期":"2024-09-18","价格(元)":8.87,"参考财报日期":"2024-06-30","TTM净利润(亿元)":8.654,"扣非PE":18.894,"扣非净利润同比增长率(%)":-28.482,"PEG":null}]}],"comparison_table":[{"股票代码":"300760.SZ","股票名称":"迈瑞医疗","角色":"目标股票","当前价格":199.99,"当前扣非PE(TTM)":28.635,"动态PE":24.023,"当前PEG":NaN,"净利润增长率":"-28.497%","当前PB":5.48,"当前PS":7.331,"备注":"比较 2024-09-30 vs 2025-09-30；利润表字段 DEDUCT_PARENT_NETPROFIT_YOY；PEG因PE或增速为非正值而置为None"},{"股票代码":"688271.SH","股票名称":"联影医疗","角色":"相似股票","当前价格":130.32,"当前扣非PE(TTM)":67.151,"动态PE":71.907,"当前PEG":0.529,"净利润增长率":"126.941%","当前PB":5.162,"当前PS":8.8,"备注":"联影医疗是迈瑞医疗在医学影像领域（如CT、MRI等）的主要国内竞争对手之一，两者在高端医疗影像设备市场存在直接竞争关系，都致力于技术创新和国产替代。"},{"股票代码":"300003.SZ","股票名称":"乐普医疗","角色":"相似股票","当前价格":16.24,"当前扣非PE(TTM)":69.903,"动态PE":22.863,"当前PEG":2.481,"净利润增长率":"28.176%","当前PB":1.687,"当前PS":4.785,"备注":"乐普医疗是国内领先的心血管领域医疗器械公司，虽然核心领域与迈瑞有所不同，但在监护、诊断等领域存在部分重叠和竞争，同属于A股医疗器械板块的重要龙头企业，市场表现和行业政策对其均有影响。"}]}